Fulminant viral hepatitis.
D000208:Acute Disease; D058186:Acute Kidney Injury / Q000209:etiology; D000596:Amino Acids / Q000097:blood; D000641:Ammonia / Q000097:blood; D000818:Animals; D001921:Brain / Q000187:drug effects; D001927:Brain Diseases / Q000134:cerebrospinal fluid / Q000209:etiology / Q000378:metabolism; D001929:Brain Edema / Q000209:etiology; D003427:Cross Circulation; D005260:Female; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000097:blood / Q000209:etiology / Q000628:therapy; D006506:Hepatitis A / Q000150:complications*; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D008115:Liver Regeneration; D011517:Prothrombin Time; D013552:Swine; D014364:Tryptophan / Q000097:blood / Q000378:metabolism
D000596:Amino Acids; D007980:Levodopa; D000641:Ammonia; D014364:Tryptophan; D006493:Heparin